Wasim K. Bleibel is an associate in the Chicago office of Locke Lord LLP where he is a member of the Firm’s Intellectual Property group. Wasim concentrates his practice on complex intellectual property litigation matters with a primary emphasis on disputes involving the Hatch-Waxman provisions of the Patent Act and the Federal Food, Drug and Cosmetic Act.
He has a broad range of experience in these actions including pre-litigation activities, Paragraph IV Certifications, fact and expert discovery, claim construction, motion practice, pre-trial, trial, and post-trial phases.
In addition to his Hatch-Waxman practice, Wasim has significant experience involving patent and trademark litigation and prosecution in other areas including mechanical engineering, chemical formulations, and medical devices.
Wasim also has experience in seed and agricultural biotechnology matters representing clients from seed producers, to seed dealers and distributors, to seedsmen’s errors and omissions insurers.
Prior to his legal career, Wasim was a senior research scientist at the University of Chicago, where he worked to identify genetic determinants contributing to a patient’s sensitivity to chemotherapeutic agents. His contributions resulted in his laboratory being the first to demonstrate that drug sensitivity to chemotherapy is a heritable genetic trait and that these responses vary between and amongst populations.
Representative Experience :
- Helsinn Healthcare S.A. v. Zydus Pharmaceuticals (USA) Inc. et al. (D. N.J. Ongoing) – Representing generic drug manufacturer in Hatch-Waxman litigation concerning injectable medication used to prevent and treat chemotherapy-induced nausea and vomiting.
- Shire Development LLC, et al. v. Zydus Pharmaceuticals (USA) Inc. et al (D. Del. Ongoing) – Represented generic drug manufacturer in Hatch-Waxman litigation concerning oral formulations used to treat ulcerative colitis.
- Hawk Technology Systems, LLC v. Gold Coast Group, Ltd. (N.D. Ill. Settled) – Represented defendant in patent infringement suit involving software and method patents.
- In re: Method of Processing Ethanol Byproducts And Related Subsystems (ʼ858) Patent Litigation (S.D. Ind.): Represented defendant renewable energy company in patent litigation concerning the production of clean burning ethanol. All patents held invalid and not infringed.
- Warner Chilcott Company LLC v. Zydus Pharmaceuticals (USA) Inc. et al (D. Del. Settled) – Represented generic drug manufacturer in Hatch-Waxman litigation concerning oral formulations used to treat ulcerative colitis.
Professional History :
- Associate, Locke Lord LLP
- Associate, Levenfeld Pearlstein, LLC (2011-2012)
- Senior Research Technician, The University of Chicago Department of Medicine (2003-2008)
Professional Affiliations :
- The Richard Linn American Inn of Court
- Treasurer (2016 – 2017)
- Membership Chair (2014-2016)
- Events Chair (2013-2014)
- Associate Member (2011-present)
- Linn Inn Alliance Advisory Council
- Liaison for the Richard Linn American Inn of Court
- Intellectual Property Law Association of Chicago
- Young Members Committee
- Co-Vice Chair (2016-present)
- Chair (2014-2016)
- Vice-chair (2012-2014)
- Biotechnology Committee
- Co-Chair (2011-2013)
- Young Members Committee
- American Writers Museum
- Chicago Founders Circle Member (2015-present)
- Supreme Court Historical Society
- Member (2016-present)
- American Bar Association
- Biotechnology Committee
- Co-Chair (2012-2014)
- Vice-Chair (2011-2012)
- Biotechnology Committee
- American Intellectual Property Law Association
- International Trademark Association
Education :
- J.D., John Marshall Law School, 2011
- Peking University, Beijing, China, 2009
- B.A., Chemistry, Michigan State University, 2003
Admissions : Illinois
Cost
Rate : $$$
